Annual CFO
-$64.09 M
+$78.38 M+55.01%
30 September 2024
Summary:
Twist Bioscience annual cash flow from operations is currently -$64.09 million, with the most recent change of +$78.38 million (+55.01%) on 30 September 2024. During the last 3 years, it has risen by +$48.15 million (+42.90%). TWST annual CFO is now -66.08% below its all-time high of -$38.59 million, reached on 30 September 2016.TWST Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFO
-$15.32 M
-$8.94 M-140.20%
30 September 2024
Summary:
Twist Bioscience quarterly cash flow from operations is currently -$15.32 million, with the most recent change of -$8.94 million (-140.20%) on 30 September 2024. Over the past year, it has increased by +$7.65 million (+33.31%). TWST quarterly CFO is now -1109.16% below its all-time high of -$1.27 million, reached on 30 September 2022.TWST Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFO
-$64.09 M
+$5.38 M+7.75%
30 September 2024
Summary:
Twist Bioscience TTM cash flow from operations is currently -$64.09 million, with the most recent change of +$5.38 million (+7.75%) on 30 September 2024. Over the past year, it has increased by +$47.28 million (+42.45%). TWST TTM CFO is now -300.19% below its all-time high of -$16.02 million, reached on 31 December 2017.TWST TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TWST Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +55.0% | +33.3% | +42.5% |
| 3 y3 years | +42.9% | +67.2% | +52.2% |
| 5 y5 years | +27.1% | +56.1% | +36.6% |
TWST Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +55.0% | -1109.2% | +71.7% | at high | +59.4% |
| 5 y | 5 years | at high | +55.0% | -1109.2% | +73.9% | at high | +59.4% |
| alltime | all time | -66.1% | +55.0% | -1109.2% | +73.9% | -300.2% | +59.4% |
Twist Bioscience Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | -$64.09 M(-55.0%) | -$15.32 M(+140.2%) | -$64.09 M(-7.7%) |
| June 2024 | - | -$6.38 M(-67.2%) | -$69.48 M(-19.7%) |
| Mar 2024 | - | -$19.42 M(-15.5%) | -$86.51 M(-22.3%) |
| Dec 2023 | - | -$22.97 M(+11.0%) | -$111.38 M(-21.8%) |
| Sept 2023 | -$142.47 M(+14.5%) | -$20.70 M(-11.6%) | -$142.47 M(+15.8%) |
| June 2023 | - | -$23.41 M(-47.1%) | -$123.04 M(-8.0%) |
| Mar 2023 | - | -$44.29 M(-18.1%) | -$133.75 M(+1.5%) |
| Dec 2022 | - | -$54.07 M(+4167.6%) | -$131.80 M(+6.0%) |
| Sept 2022 | -$124.39 M(+10.8%) | -$1.27 M(-96.3%) | -$124.39 M(-21.2%) |
| June 2022 | - | -$34.13 M(-19.4%) | -$157.92 M(+4.1%) |
| Mar 2022 | - | -$42.34 M(-9.2%) | -$151.76 M(+13.3%) |
| Dec 2021 | - | -$46.65 M(+34.0%) | -$133.97 M(+19.4%) |
| Sept 2021 | -$112.24 M | -$34.80 M(+24.5%) | -$112.24 M(+9.4%) |
| June 2021 | - | -$27.96 M(+13.9%) | -$102.64 M(+4.6%) |
| Mar 2021 | - | -$24.55 M(-1.5%) | -$98.15 M(-25.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | - | -$24.93 M(-1.1%) | -$132.27 M(-7.0%) |
| Sept 2020 | -$142.25 M(+61.8%) | -$25.20 M(+7.4%) | -$142.25 M(+1.3%) |
| June 2020 | - | -$23.47 M(-60.0%) | -$140.41 M(+1.0%) |
| Mar 2020 | - | -$58.67 M(+68.0%) | -$139.03 M(+37.4%) |
| Dec 2019 | - | -$34.91 M(+49.5%) | -$101.17 M(+15.0%) |
| Sept 2019 | -$87.94 M(+32.9%) | -$23.36 M(+5.8%) | -$87.94 M(+8.2%) |
| June 2019 | - | -$22.08 M(+6.1%) | -$81.28 M(+6.8%) |
| Mar 2019 | - | -$20.81 M(-4.0%) | -$76.14 M(+6.0%) |
| Dec 2018 | - | -$21.68 M(+29.9%) | -$71.83 M(+8.6%) |
| Sept 2018 | -$66.16 M(+29.0%) | -$16.70 M(-1.5%) | -$66.16 M(+33.8%) |
| June 2018 | - | -$16.94 M(+2.6%) | -$49.47 M(+52.1%) |
| Mar 2018 | - | -$16.51 M(+3.1%) | -$32.53 M(+103.1%) |
| Dec 2017 | - | -$16.02 M | -$16.02 M |
| Sept 2017 | -$51.30 M(+32.9%) | - | - |
| Sept 2016 | -$38.59 M | - | - |
FAQ
- What is Twist Bioscience annual cash flow from operations?
- What is the all time high annual CFO for Twist Bioscience?
- What is Twist Bioscience annual CFO year-on-year change?
- What is Twist Bioscience quarterly cash flow from operations?
- What is the all time high quarterly CFO for Twist Bioscience?
- What is Twist Bioscience quarterly CFO year-on-year change?
- What is Twist Bioscience TTM cash flow from operations?
- What is the all time high TTM CFO for Twist Bioscience?
- What is Twist Bioscience TTM CFO year-on-year change?
What is Twist Bioscience annual cash flow from operations?
The current annual CFO of TWST is -$64.09 M
What is the all time high annual CFO for Twist Bioscience?
Twist Bioscience all-time high annual cash flow from operations is -$38.59 M
What is Twist Bioscience annual CFO year-on-year change?
Over the past year, TWST annual cash flow from operations has changed by +$78.38 M (+55.01%)
What is Twist Bioscience quarterly cash flow from operations?
The current quarterly CFO of TWST is -$15.32 M
What is the all time high quarterly CFO for Twist Bioscience?
Twist Bioscience all-time high quarterly cash flow from operations is -$1.27 M
What is Twist Bioscience quarterly CFO year-on-year change?
Over the past year, TWST quarterly cash flow from operations has changed by +$7.65 M (+33.31%)
What is Twist Bioscience TTM cash flow from operations?
The current TTM CFO of TWST is -$64.09 M
What is the all time high TTM CFO for Twist Bioscience?
Twist Bioscience all-time high TTM cash flow from operations is -$16.02 M
What is Twist Bioscience TTM CFO year-on-year change?
Over the past year, TWST TTM cash flow from operations has changed by +$47.28 M (+42.45%)